Accelerated concussion recovery rates of this magnitude have broad implications for public health, workforce productivity, and contact sports. COLORADO SPRINGS, Colo., Feb. 10, 2026 /PRNewswire/ -- ...
Treatment with TSND-201 was associated with statistically significant improvement in PTSD symptoms. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 ...
Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior bevacizumab and mirvetuximab soravtansine treatment. Preliminary phase 1a/b study ...
Alixorexton at all doses demonstrated significant improvements from baseline in mean sleep latency compared with placebo. The Food and Drug Administration (FDA) has granted Breakthrough Therapy ...
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results